Exelixis
EXEL
#1752
Rank
NZ$20.80 B
Marketcap
NZ$82.76
Share price
-2.45%
Change (1 day)
16.72%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company